← Back to headlines
Organogenesis Projects Significant Revenue Decline by 2026 Due to CMS Policy Changes
Organogenesis anticipates a substantial revenue decline of 25%-38% by 2026, attributing the projected decrease to market disruption driven by policy changes from the Centers for Medicare & Medicaid Services (CMS).
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Goldman Sachs Expands Asset Management with LCN Capital Partners Acquisition
13m ago
US Coast Guard Lifts 12-Year Entry Restriction on Nigeria-Bound Ships
31m ago
Hesai Group, Amer Sports, and VNET Group Report Q2 Earnings
33m ago
German Retail Giant Expands in Slovakia, Finnish Counterpart Cuts Jobs
38m ago